首页> 外文OA文献 >Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases
【2h】

Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases

机译:内镜超声引导下细针穿刺抽吸术可疑胰腺转移的准确性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract\ud \ud \ud \ud Background\ud \ud Metastases to the pancreas are rare, and usually mistaken for primary pancreatic cancers. This study aimed to describe the histology results of solid pancreatic tumours obtained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for diagnosis of metastases to the pancreas.\ud \ud \ud \ud Methods\ud \ud In a retrospective review, patients with pancreatic solid tumours and history of previous extrapancreatic cancer underwent EUS-FNA from January/1997 to December/2010. Most patients were followed-up until death and some of them were still alive at the end of the study. The performance of EUS-FNA for diagnosis of pancreatic metastases was analyzed. Symptoms, time frame between primary tumour diagnosis and the finding of metastases, and survival after diagnosis were also analyzed.\ud \ud \ud \ud Results\ud \ud 37 patients underwent EUS-FNA for probable pancreas metastases. Most cases (65%) presented with symptoms, especially upper abdominal pain (46%). Median time between detection of the first tumour and the finding of pancreatic metastases was 36 months. Metastases were confirmed in 32 (1.6%) cases, 30 of them by EUS-FNA, and 2 by surgery. Other 5 cases were non-metastatic. Most metastases were from lymphoma, colon, lung, and kidney. Twelve (32%) patients were submitted to surgery. Median survival after diagnosis of pancreatic metastases was 9 months, with no difference of survival between surgical and non-surgical cases. Sensitivity, specificity, positive and negative predictive values, and accuracy of EUS-FNA with histology analysis of the specimens for diagnosis of pancreatic metastases were, respectively, 93.8%, 60%, 93.8%, 60% and 89%.\ud \ud \ud \ud Conclusion\ud \ud EUS-FNA with histology of the specimens is a sensitive and accurate method for definitive diagnosis of metastatic disease in patients with a previous history of extrapancreatic malignancies.
机译:摘要\ ud \ ud \ ud \ ud \ ud背景\ ud \ ud胰腺转移很少见,通常被误认为原发性胰腺癌。这项研究旨在描述通过内镜超声引导下细针穿刺抽吸术(EUS-FNA)获得的用于诊断胰腺转移的实体胰腺肿瘤的组织学结果。\ ud \ ud \ ud \ ud方法\ ud \ ud回顾性回顾,从1997年1月/ 2010年12月至2010年12月,对具有胰腺实体瘤和既往胰腺外癌病史的患者进行了EUS-FNA。大多数患者都被随访直至死亡,其中一些患者在研究结束时还活着。分析了EUS-FNA诊断胰腺转移的性能。还分析了症状,从原发肿瘤诊断到发现转移灶的时间范围以及诊断后的存活率。37例因胰腺转移的患者接受了EUS-FNA治疗。大多数病例(65%)表现出症状,尤其是上腹部疼痛(46%)。从发现第一个肿瘤到发现胰腺转移灶的中位时间为36个月。在32例(1.6%)病例中证实了转移,其中EUS-FNA证实了30例,手术证实了2例。其他5例为非转移性。大多数转移来自淋巴瘤,结肠,肺和肾脏。十二名(32%)患者接受了手术。诊断为胰腺转移后的中位生存期为9个月,手术和非手术病例的生存期无差异。 EUS-FNA的组织学分析诊断胰腺转移的敏感性,特异性,阳性和阴性预测值和准确性分别为93.8%,60%,93.8%,60%和89%。结论:EUS-FNA标本的组织学检查是一种准确,准确的方法,可用于明确诊断胰腺前恶性肿瘤患者的转移性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号